🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
The goal of this clinical trial is to evaluate the efficacy of investigator...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-09-13
Trial ID
NCT05954442
Treatments Being Tested
To assess the efficacy and safety of adebrelimab in combination with apatin...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Science and Technology
Start Date
2024-07-15
Trial ID
NCT06464614
Treatments Being Tested
In this study, a 24-week, single blinded, randomized controlled clinical tr...
Status
Completed
Location
Linda Zhong
Start Date
2018-10-22
Trial ID
NCT03582423
Treatments Being Tested
Phase II clinical trial of PD-L1 in combination with vinorelbine + cyclopho...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-09-10
Trial ID
NCT06771609
Phase II: To evaluate the safety and tolerability of IAE0972 combined with ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06719479
Treatments Being Tested
CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-05-15
Trial ID
NCT05861830
The purpose of this study is to evaluate the efficacy and safety of pertuzu...
Status
Completed
Location
Aichi Cancer Center
Start Date
2015-08-01
Trial ID
NCT02514681
The study addresses two primary questions, according to its factorial desig...
Status
Terminated
Location
Ospedali Riuniti di Bergamo
Start Date
2010-11
Trial ID
NCT01989858